VEKLURY
Google image searchProduct monograph
Active ingredient
remdesivir, 100 MG/VIAL
DIN: 02502143
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE-DOSE VIAL
Schedule: Prescription
Company: GILEAD SCIENCES CANADA INC
Date: 16-OCT-2020
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AB — Nucleosides and nucleotides excl. reverse transcriptase inhibitors (ATC, ATC/DDD)
- J05AB16 — REMDESIVIR (ATC/DDD)
Reference brand drug: Veklury
